Also Read: 5 Eye-Opening Things Science Got Wrong (And Right) about Ozempic Should I stop my GLP-1 medication if Im concerned about bone health
Antmen FM, Fedaioglu Z, Acar D, Sayar AK, Yavuz IE, Ada E, Karakose B, Rzayeva L, Demircan S, Kardouh F, Senay S, Kolgazi M, Suyen G, Oz-Arslan D (2024) Exploring Liraglutide in Lithium-Pilocarpine-Induced Temporal Lobe Epilepsy Model in Rats: Impact on Inflammation, Mitochondrial Function, and Behavior
Consult a medical professional prior to initiating any new regimen
doi: 10.1002/PHAR.4607 45 LiuZBianNWuSFanYLiHYuJet al
March 31st, 2025: Plaintiffs Push Back on Ozempic Dismissal Motion, Accuse Drug Makers of Downplaying GI Risks Plaintiffs in the GLP-1 drug litigationincluding claims involving Ozempic, Wegovy, and Mounjarohave asked a federal judge to reject dismissal efforts by Novo Nordisk and Eli Lilly
Obesity (Silver Spring, Md.) , 21 (8), 16021607